| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90437c875c599337a97df533886fd4c7 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 |
| filingDate |
2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a68c30e1ff2749959509e44d839222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52588ab7ddef548bcbd222fd58bfb2da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94a4c4c7e6aad98f72469e5c900b9fbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b33b847ef4bfc6ab477481bee530422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52997ebb8c980f296f4ea643b755d87a |
| publicationDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2410095-C2 |
| titleOfInvention |
Agent for increasing efficacy and reducing toxicity of antineoplastic preparations |
| abstract |
FIELD: medicine. n SUBSTANCE: substance of the invention consists in administration of 3-oxy-6-methyl-2-ethyl-pyridine succinate (Mexidol) as an agent for reducing toxicity and increasing antineoplastic efficacy of etoposide. n EFFECT: reduced toxicity and increased efficacy of etoposide-containing schedules of antineoplastic chemotherapy ensured by antioxidant action of Mexidol. n 5 dwg, 3 ex |
| priorityDate |
2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |